These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 49892)

  • 41. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
    Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC
    J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
    Molinatti GM; Limone P
    Minerva Med; 1981 Mar; 72(12):715-32. PubMed ID: 6164019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dynamic tests of the function of the renin-angiotensin-aldosterone system].
    Horký K; Küchel O
    Vnitr Lek; 1969 Feb; 15(2):105-13. PubMed ID: 4305779
    [No Abstract]   [Full Text] [Related]  

  • 44. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
    Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
    J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Radioimmunoassays of aldosterone and plasma renin activity. Application to the diagnosis of primary aldosteronism].
    Corvol P; Ménard J; Bertagna X
    Ann Endocrinol (Paris); 1973; 34(1):57-65. PubMed ID: 4353078
    [No Abstract]   [Full Text] [Related]  

  • 46. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fasting in obese females. II. Plasma renin activity and urinary aldosterone.
    Verdy M; de Champlain J
    Can Med Assoc J; 1968 Jun; 98(22):1034-7. PubMed ID: 4297375
    [No Abstract]   [Full Text] [Related]  

  • 50. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the sympathetic nervous system in regulating renin and aldosterone production in man.
    Gordon RD; Küchel O; Liddle GW; Island DP
    J Clin Invest; 1967 Apr; 46(4):599-605. PubMed ID: 6021207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rate of activation of renin-angiotensin-aldosterone axis and sodium intake in rats.
    Holtzman E; Braley LM; Menachery A; Williams GH; Hollenberg NK
    Am J Physiol; 1989 May; 256(5 Pt 2):H1311-5. PubMed ID: 2655479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Renin-angiotensin-aldosterone system from the clinical viewpoint].
    Siegenthaler W; Werning C
    Dtsch Med Wochenschr; 1970 Feb; 95(8):411-8. PubMed ID: 4313039
    [No Abstract]   [Full Text] [Related]  

  • 54. [Renin-angiotensin-aldosterone system in water-electrolyte homeostasis].
    Anghel S
    Med Interna (Bucur); 1972 May; 24(5):521-8. PubMed ID: 4340438
    [No Abstract]   [Full Text] [Related]  

  • 55. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):109-16. PubMed ID: 8771911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
    Douillard C; Houillier P; Nussberger J; Girerd X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):192-201. PubMed ID: 27177498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
    Williams GH; Dluhy RG; Moore TJ
    Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mineralocorticoid function of the adrenal cortex in adolescent girls with thyrotoxicosis].
    Zhurova MV; Natarov VV; Rybina LV
    Probl Endokrinol (Mosk); 1978; 24(1):25-8. PubMed ID: 634943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Renin and aldosterone in idiopathic edema].
    Werning C; Baumann K; Gysling E; Stiel D; Vetter W; Weidmann P; Siegenthaler W
    Klin Wochenschr; 1969 Dec; 47(23):1256-63. PubMed ID: 5383799
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cause of angiotensin resistance in chronic pyelonephritis].
    Koch HG; Thienemann V; Commichau R
    Klin Wochenschr; 1970 Dec; 48(23):1385-8. PubMed ID: 4329679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.